Vistakon Division of Johnson & Johnson Vision Care Inc. has announced the U.S. introduction of 1-Day Acuvue TruEye (narafilcon A) contact lenses.
Jacksonville, FL-Vistakon Division of Johnson & Johnson Vision Care Inc. has announced the U.S. introduction of 1-Day Acuvue TruEye (narafilcon A) contact lenses (CLs). 1-Day Acuvue TruEye is now available at some U.S. eyecare professionals’ (ECP’s) offices, with distribution expected to grow in the coming months.
Advertisement
The lens features Hydraclear 1 Technology, which attracts tear film to help maintain the natural ocular environment for all-day comfort, High O2 Consumption, allowing 100 percent corneal oxygen consumption at all points across minus and plus powers, and Class-1 UV-blocking, offering patients the highest level of UV protection in a contact lens, blocking approximately 96 percent of UV-A rays and greater than 99 percent of UV-B rays that reach the lens.
1-Day Acuvue TruEye (narafilcon A) will gradually replace 1-Day Acuvue TruEye (narafilcon B), which was launched in the U.S. in 2010.
Dave Brown, Vistakon president, said: “Our aim is to quickly transition to 1-Day Acuvue TruEye (narafilcon A), and we will provide doctors with a number of tools to help smooth the conversion process for ECPs and patients. We are confident that 1-Day Acuvue TruEye (narafilcon A) will help doctors make more patients happy, and drive additional patient referrals-the key to practice growth.”
